LATEST NEWS AND EVENTS
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE Junction
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* negative […]
Study finds Regimen that doesn’t include Radiation is Better than current Standard
A German study finds a 30% reduction in the risk of death among […]
FDA Advisory Panel votes to limit some EC patients’ access to immunotherapy
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with advanced […]
Medical Advances ● Advocacy Campaigns ● Awareness Efforts
We respect your privacy and will never share your information.